VEGF is critical for stem cell-mediated cardioprotection and a crucial paracrine factor for defining the age threshold in adult and neonatal stem cell function.
about
Use of mesenchymal stem cells for therapy of cardiac diseaseThe role of N-acetyltransferase 8 in mesenchymal stem cell-based therapy for liver ischemia/reperfusion injury in ratsHyaluronan mixed esters of butyric and retinoic acid affording myocardial survival and repair without stem cell transplantation.TLR4 inhibits mesenchymal stem cell (MSC) STAT3 activation and thereby exerts deleterious effects on MSC-mediated cardioprotection.Toll-like receptor 2 mediates mesenchymal stem cell-associated myocardial recovery and VEGF production following acute ischemia-reperfusion injuryBone marrow mesenchymal stem cell-derived vascular endothelial growth factor attenuates cardiac apoptosis via regulation of cardiac miRNA-23a and miRNA-92a in a rat model of myocardial infarctionStromal derived factor-1 mediates the lung regenerative effects of mesenchymal stem cells in a rodent model of bronchopulmonary dysplasia.Signal transducer and activator of transcription 3-stimulated hypoxia inducible factor-1alpha mediates estrogen receptor-alpha-induced mesenchymal stem cell vascular endothelial growth factor productionSca-1+ cardiac stem cells mediate acute cardioprotection via paracrine factor SDF-1 following myocardial ischemia/reperfusionBone marrow mesenchymal cells: how do they contribute to tissue repair and are they really stem cells?Paracrine mechanisms of stem cell reparative and regenerative actions in the heartTNF receptor 2, not TNF receptor 1, enhances mesenchymal stem cell-mediated cardiac protection following acute ischemia.Effects of vascular endothelial growth factor 165 on bone tissue engineeringVEGF/SDF-1 promotes cardiac stem cell mobilization and myocardial repair in the infarcted heart.Human BM stem cells initiate angiogenesis in human islets in vitro.The secretome of myocardial telocytes modulates the activity of cardiac stem cells.Molecular imaging of mesenchymal stem cell: mechanistic insight into cardiac repair after experimental myocardial infarction.Culture and properties of adipose-derived mesenchymal stem cells: characteristics in vitro and immunosuppression in vivoMesenchymal stem cells for cardiac regeneration: translation to bedside realityHarvest tissue source does not alter the protective power of stromal cell therapy after intestinal ischemia and reperfusion injury.Targeted Delivery of VEGF after a Myocardial Infarction Reduces Collagen Deposition and Improves Cardiac Function.Mesenchymal stem cells improve cardiac conduction by upregulation of connexin 43 through paracrine signaling.Cardiac stem cells: A promising treatment option for heart failureChanges in the Anatomic and Microscopic Structure and the Expression of HIF-1α and VEGF of the Yak Heart with Aging and HypoxiaEmerging Concepts in Paracrine Mechanisms in Regenerative Cardiovascular Medicine and Biology.Ischemia/Reperfusion injury protection by mesenchymal stem cell derived antioxidant capacity.High glucose concentration in cell culture medium does not acutely affect human mesenchymal stem cell growth factor production or proliferationMechanisms of load dependency of myocardial ischemia reperfusion injury.Pharmacologically active microcarriers influence VEGF-A effects on mesenchymal stem cell survival.Mesenchymal stem cells conditioned with glucose depletion augments their ability to repair-infarcted myocardium.Human endometrial stem cells confer enhanced myocardial salvage and regeneration by paracrine mechanisms.IL-18 binding protein-expressing mesenchymal stem cells improve myocardial protection after ischemia or infarction.A comparison of the reparative and angiogenic properties of mesenchymal stem cells derived from the bone marrow of BALB/c and C57/BL6 mice in a model of limb ischemia.MEK, p38, and PI-3K mediate cross talk between EGFR and TNFR in enhancing hepatocyte growth factor production from human mesenchymal stem cells.Bone marrow-derived mesenchymal stem cells in fibrin augment angiogenesis in the chronically infarcted myocardium.Mesenchymal stem cells and their conditioned medium improve integration of purified induced pluripotent stem cell-derived cardiomyocyte clusters into myocardial tissueSecreted Frizzled-related protein 2 as a target in antifibrotic therapeutic intervention.Sorafenib therapy for metastatic renal carcinoma in patients with low cardiac ejection fraction: report of two cases and literature review.Modification of mesenchymal stem cells for cardiac regeneration.HGF/c-Met signaling mediated mesenchymal stem cell-induced liver recovery in intestinal ischemia reperfusion model.
P2860
Q27003127-B29518EC-8774-4030-8A62-AD5AEFCBE679Q28541169-E6174606-9020-4609-9963-91340D0E0668Q28565149-8C4B6BF0-2330-48F3-93EA-DF93A4E0352EQ33769592-A31E0390-254E-45CC-8B99-C5FD6F326858Q33840741-FB0025C3-89E1-4B63-A2FA-0BC9FD75F557Q33853277-B4F878C8-F6A3-40BB-AADC-D86FE6A63F28Q33896429-3A67D862-72D6-4894-95EB-FE9C3AF3D3FCQ34089612-7E23C61A-5290-458F-AE4A-A57379D45FAFQ34110874-432434D5-611F-489F-BB1D-7ECBBA412505Q34203516-B6CF230A-D81E-4F34-9BC0-BC0167964D75Q34494230-BD5E0694-8012-4CA9-9CBA-C39760DFE917Q34789088-A39830D0-B6B0-4739-8CC7-7DC41CA4ED1CQ35077816-7DC24EF8-A99B-4715-8BB2-829EE97DEFD8Q35114758-30DCBB65-B276-45E6-B526-4776AACDDCF9Q35158696-62C93C65-E7FF-401C-AA72-D606EB5972B9Q35692203-2E5AEA02-5AAA-4786-B50C-683E207B9AB0Q35739930-DC155CD9-DDF6-4D53-AF8C-F235ADE1CDF1Q36014140-2304FF89-34E3-404B-967D-1FB98A2BBE95Q36056155-A5D0CA42-8E45-4FF8-B4D6-D376A1735165Q36114386-F12B2F16-8B4C-47CA-A1FC-1938600C08C4Q36119864-5F4E600B-355A-45F4-90A6-AFEF66848F23Q36593007-A17E8945-D729-4F61-966A-F726817B71F3Q36603788-F8943584-7E42-4FC1-8C2C-89D4703E2964Q36620599-903CE55F-B9E9-4FD2-852D-791714EF5E4DQ36920724-AB26CEEA-9B3B-4AE1-AA2A-59ACB24E034FQ37139569-B6F8915D-A18B-4033-AC0E-AA4F11FC149AQ37217978-6F452BD9-DB0D-4969-A04C-84252F8BFB15Q37285384-EF3CF786-7A25-47A9-908A-5A3413665179Q37295351-4E1852F0-6473-413F-BA17-28498DB01348Q37296266-6D691F8A-AC50-4B1D-A711-58F67224706AQ37350906-10BCD8B2-C037-4148-A1FD-2731BA93EA98Q37363758-47AB3F09-4F49-46E7-9A65-B166369BBD7EQ37376911-7287DA86-3AED-46DF-B777-90EDD877B11AQ37421053-F1AA1210-584C-489A-9AB2-49C2A332E436Q37422757-E38FA030-A8EF-459B-8BE2-5448823C329AQ37610637-5602D3DF-95EE-4A53-A2DC-4E6894004126Q37629036-B73AB785-913D-4DE5-A45D-DC0F8482267EQ37656300-EB71AF71-63EE-4607-B02D-A2E071316693Q37687406-14522CD7-9286-421B-A5DD-F0563267193DQ37730269-60677336-3C7D-413F-BEF7-5BEB5159CDFB
P2860
VEGF is critical for stem cell-mediated cardioprotection and a crucial paracrine factor for defining the age threshold in adult and neonatal stem cell function.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
VEGF is critical for stem cell ...... d neonatal stem cell function.
@en
VEGF is critical for stem cell ...... d neonatal stem cell function.
@nl
type
label
VEGF is critical for stem cell ...... d neonatal stem cell function.
@en
VEGF is critical for stem cell ...... d neonatal stem cell function.
@nl
prefLabel
VEGF is critical for stem cell ...... d neonatal stem cell function.
@en
VEGF is critical for stem cell ...... d neonatal stem cell function.
@nl
P2093
P2860
P1476
VEGF is critical for stem cell ...... nd neonatal stem cell function
@en
P2093
Daniel R Meldrum
Jiangning Tan
Meijing Wang
Nathan M Novotny
Paul R Crisostomo
Troy A Markel
P2860
P304
P356
10.1152/AJPHEART.00565.2008
P577
2008-10-10T00:00:00Z